Advent Private Equity Fund Iii C Ltd Partnership - Net Worth and Insider Trading

Advent Private Equity Fund Iii C Ltd Partnership Net Worth

The estimated net worth of Advent Private Equity Fund Iii C Ltd Partnership is at least $588,966 dollars as of 2024-11-07. Advent Private Equity Fund Iii C Ltd Partnership is the Member of 13(d) Group of Emergent BioSolutions Inc and owns about 64,018 shares of Emergent BioSolutions Inc (EBS) stock worth over $588,966. Details can be seen in Advent Private Equity Fund Iii C Ltd Partnership's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Advent Private Equity Fund Iii C Ltd Partnership has not made any transactions after 2007-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Advent Private Equity Fund Iii C Ltd Partnership

Advent Private Equity Fund Iii C Ltd Partnership Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Advent Private Equity Fund Iii C Ltd Partnership owns 1 companies in total, including Emergent BioSolutions Inc (EBS) .

Click here to see the complete history of Advent Private Equity Fund Iii C Ltd Partnership’s form 4 insider trades.

Insider Ownership Summary of Advent Private Equity Fund Iii C Ltd Partnership

Ticker	Comapny	Transaction Date	Type of Owner
EBS	Emergent BioSolutions Inc	2007-03-08	other: Member of 13(d) Group

Advent Private Equity Fund Iii C Ltd Partnership Latest Holdings Summary

Advent Private Equity Fund Iii C Ltd Partnership currently owns a total of 1 stock. Advent Private Equity Fund Iii C Ltd Partnership owns 64,018 shares of Emergent BioSolutions Inc (EBS) as of March 8, 2007, with a value of $588,966.

Latest Holdings of Advent Private Equity Fund Iii C Ltd Partnership

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
EBS	Emergent BioSolutions Inc	2007-03-08	64,018	9.20	588,966

Holding Weightings of Advent Private Equity Fund Iii C Ltd Partnership

Advent Private Equity Fund Iii C Ltd Partnership Form 4 Trading Tracker

According to the SEC Form 4 filings, Advent Private Equity Fund Iii C Ltd Partnership has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 0 shares on March 8, 2007, which brought Advent Private Equity Fund Iii C Ltd Partnership around $0.

Insider Trading History of Advent Private Equity Fund Iii C Ltd Partnership

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Advent Private Equity Fund Iii C Ltd Partnership Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Advent Private Equity Fund Iii C Ltd Partnership Ownership Network

Ownership Network List of Advent Private Equity Fund Iii C Ltd Partnership

No Data

Ownership Network Relation of Advent Private Equity Fund Iii C Ltd Partnership

Advent Private Equity Fund Iii C Ltd Partnership Owned Company Details

What does Emergent BioSolutions Inc do?

Who are the key executives at Emergent BioSolutions Inc?

Advent Private Equity Fund Iii C Ltd Partnership is the other: Member of 13(d) Group of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .

Emergent BioSolutions Inc (EBS) Insider Trades Summary

Over the past 18 months, Advent Private Equity Fund Iii C Ltd Partnership made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 16,449 shares made by Kathryn C Zoon ,

In summary, during the past 3 months, insiders sold 0 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,449 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,449 shares.

Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Emergent BioSolutions Inc Insider Transactions

No Available Data

Advent Private Equity Fund Iii C Ltd Partnership Mailing Address

Above is the net worth, insider trading, and ownership report for Advent Private Equity Fund Iii C Ltd Partnership. You might contact Advent Private Equity Fund Iii C Ltd Partnership via mailing address: 25 Buckingham Gate, London England X0 0000000000.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.